Transcript:
Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual CareByPooja Gokhale, PharmD,Lorenzo Villa Zapata, PhDNovember 18th 2025
Coverage With Evidence Development Study Shows Benefits in Patients With Migraine Treated With Remote Electrical NeuromodulationByAndrea Synowiec, DO,Alit Stark-Inbar, PhD,Dolores Dominguez Santamaria, MD,Matthew Fickie, MD,Stephen Ross, MDApril 8th 2025